News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Cree_Bruce_san francisco_web.jpg)
Ozanimod shows long-term safety, despite a pandemic
- Author:
- Jim Kling
Open-label study confirms efficacy and COVID-19–related safety.
News
B-cell therapy for MS may impact COVID-19 vaccination
- Author:
- Jim Kling
A prospective study found improved neutralizing antibody response with more time elapsed since therapy and vaccination.
News
Aspirin fails to inhibit breast cancer recurrence
- Author:
- Jim Kling
Aspirin has been proven effective in reducing colon cancer recurrence rates, but this new randomized, controlled trial contradicts epidemiological...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/GlutenFree Bread_web.jpg)
Eating disorder may be common in celiac disease
- Author:
- Jim Kling
Avoidant/restrictive food intake disorder can be an issue, but it’s tough to distinguish from normal disease maintenance.
News
Rome IV modifications may improve IBS diagnosis
- Author:
- Jim Kling
Proposed new criteria may help specialists, but they should also help primary care physicians be more confident in making a diagnosis.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/GlutenFree Bread_web.jpg)
Eating disorder may be common in celiac disease
- Author:
- Jim Kling
Avoidant/restrictive food intake disorder can be an issue, but it’s tough to distinguish from normal disease maintenance.
News
Experimental breast cancer immunotherapy treatment passes important hurdle in pilot study
- Author:
- Jim Kling
Tumor-infiltrating lymphocytes show promise in six patients.
News
Radioactive iodine therapy linked to later malignancy
- Author:
- Jim Kling
A SEER study confirms known risks, but also finds elevated rates of breast cancer.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Murphy_James_CALIF_web.jpg)
Medicaid expansion benefits some colorectal patients, others not so lucky
- Author:
- Jim Kling
States that expanded Medicaid saw higher rates of colon cancer diagnosis in Hispanics, but not Blacks
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Atreya_Raja_N_Germ_web.jpg)
A deep dive on tofacitinib’s mode of action
- Author:
- Jim Kling
This research reveals details on the JAK inhibitor’s pharmacokinetics, including possible targets for future research.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/stomach_pain_web.jpg)
AGA clinical practice update: Expert review on managing refractory gastroparesis
- Author:
- Jim Kling
Review and expert opinion outlines treatment options and highlights similarities to functional dyspepsia.
News
Novel treatment shows early promise for gastric cancer
- Author:
- Jim Kling
The AK104 antibody treatment combined with chemotherapy demonstrated a manageable safety profile.
News
Oxaliplatin add-on not recommended for elderly with colon cancer
- Author:
- Jim Kling
A study of elderly patients with metastatic colon cancer shows no benefit and an increased neuropathy risk.
News
Abraxane still in short supply for cancer patients
- Author:
- Jim Kling
Allotments for this chemotherapy drug are waning but patients are willing to travel for treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Fatty_Liver_899359422_VIM_web.jpg)
Long COVID associated with risk of metabolic liver disease
- Author:
- Jim Kling
Metabolic-associated fatty liver disease may be another cluster phenotype of long COVID.